:?

Christina M Paluskievicz1, Mahtab Vasigh1, Piyush Rath2

  • 1Surgical Oncology, Johns Hopkins University School of Medicine, Baltimore, USA.

Cureus
|August 27, 2025
PubMed
概括

针对下癌的复发,与下淋巴结剖析相比,针对性下剖析 (TAD) 在无进展生存率上没有差异. 这表明了关降级战略的潜力.